Clinical Trials in Los Angeles

Showing 3321-3340 of 16,901 trials

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

NCT05854069

The goal of this clinical trial is to evaluate the efficacy of an adapted FAMS (Family/friend Activation to Motivate Self-care) intervention on CGM use among study participants who are CGM users. We will leverage the infrastructure of an NIDDK-funded RCT evaluating FAMS-T1D among N=280 emerging adults with T1D who have elevated hemoglobin A1c or elevated diabetes distress (NCT05820477). We anticipate at least 50% using CGM to be included in these analyses.

Type 1 Diabetes

Vanderbilt University Medical Center140 participantsStarted Apr 2023

Los Angeles, California, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

NCT05983770

This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.

Kidney Transplant Rejection

Eledon Pharmaceuticals127 participantsStarted Aug 2023

Los Angeles, California, United States • Los Angeles, California, United States • Orange, California, United States +40 more locations

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Find Trials by Condition in Los Angeles

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

Implementation of Team Clinic for Type 2 Diabetes (TCT2)

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Esophageal Temperature During PVI Using Q-DOT Micro

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease

Access Cannulation Trial II

STXBP1 and SYNGAP1 Related Disorders Natural History Study

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Individualizing Treatment for Asthma in Primary Care (Full Study)

The Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage